An observational study in Spontaneous Coronary Artery Dissection, sponsored by SCAD Alliance. Active, not recruiting at 31 sites in 2 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-06.
Sponsored by SCAD Alliance · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 13 studies in Coronary Artery Dissection, Spontaneous with a site in United States — 8 open to participants now, 9 under way, none of them phase 3. Coronary Artery Dissection, Spontaneous · United States.
Among the 13 studies in Coronary Artery Dissection, Spontaneous with a site in United States, this one is the 2nd largest by enrollment of the 10 observational ones that give a count, is the only one that started in 2019, is one of 10 observational ones, and was the 8th registered.
28 studies on the registry are indexed under Coronary Artery Dissection, Spontaneous; 18 are open to participants now.
Browse Coronary Artery Dissection, Spontaneous studies →8 of the 13 studies in Coronary Artery Dissection, Spontaneous with a site in United States are open now. Recruiting first, the newest first:
Mayo Clinic · Sites in United States
Ages 21–65
Vanderbilt University Medical Center · Sites in United States
Ages 18–100
Mayo Clinic · Sites in United States
Ages 18+ · Healthy volunteers
Mayo Clinic · Sites in United States
Ages 18+ · Women only · Healthy volunteers
Icahn School of Medicine at Mount Sinai · Sites in United States
Ages 18+ · Healthy volunteers
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 13 Coronary Artery Dissection, Spontaneous studies recruiting now, 11 (85%) set no upper age limit and 1 (8%) stops at 75 or younger; 1 takes children under 18; 5 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
13 studies; the count open now beside each. This study's row is marked.
First in 1995; this study’s year is marked. 1 started in 2019.
This study's enrollment of 2,000 is above the median of 457 across 18 observational studies indexed under Coronary Artery Dissection, Spontaneous.
Median enrollment 28 across the 3 interventional studies, 675 across the 10 observational. Of the 2 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 13 has an industry lead sponsor. The 6 most frequent:
This is the only study on the registry with SCAD Alliance as lead sponsor.
SCAD Alliance has 1 study filed under Coronary Artery Dissection, Spontaneous — fewer than ten, so there is no comparison to draw.
5 of the studies in Coronary Artery Dissection, Spontaneous with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04496687SCAD AllianceInternational Spontaneous Coronary Artery Dissection (SCAD) "iSCAD" Registry | 2026-12-31 |
| NCT07529691Vanderbilt University Medical CenterSurvey on Physical Activity and Qualify of Life in Fibromuscular Dysplasia | 2027-04-30 |
| NCT05699200Mayo ClinicA Study to Analyze the Role of Sympathetic Nervous System in Spontaneous Coronary Artery Dissection | 2027-08 |
| NCT07526766Mayo ClinicA Study Of Exercise In Patients With Spontaneous Coronary Artery Dissection And Fibromuscular Dysplasia | 2027-08-30 |
| NCT07178509Mayo ClinicA Study of SCAD Using Stress Contrast Echocardiography | 2027-09 |
Add all 5 to your calendar (.ics) → With an account.
Among the 13 studies in Coronary Artery Dissection, Spontaneous with a site in United States, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The aim of "iSCAD," the International Spontaneous Coronary Artery Dissection (SCAD) Registry, is to serve as an internationally collaborative, multicenter registry coordinated by an experienced and centralized coordinating center in an effort to increase the pace of participant recruitment, and thereby increase statistical power of studies related to SCAD.
The ultimate goal of iSCAD Registry is to facilitate the development of best practices and clinical guidelines for preventing SCAD or its recurrence. This observational study will be prospective and retrospective in its recruitment and will collect clinical information to better understand the natural history and prognosis for SCAD.
Spontaneous Coronary Artery Dissection (SCAD) is an under-diagnosed cause of acute coronary syndrome (ACS), myocardial infarction (MI) and sudden cardiac arrest. The inner lining of the coronary artery splits and allows blood to seep into the adjacent layer, forming a blockage (hematoma), or the artery continues to tear, creating a flap of tissue that blocks blood flow in the artery.
SCAD strikes generally healthy, younger individuals (average age 42) who do not have traditional cardiac risk factors. Warning signs of SCAD encompass the full range of ACS and MI symptoms, from vague to classic. The cause of SCAD is currently unknown and the psychosocial impact of SCAD is traumatizing. The work of the iSCAD Registry will encompass the physical and psychosocial study of SCAD.
Spontaneous coronary artery dissection (SCAD) is defined as the non-traumatic, non-iatrogenic separation of the coronary arterial wall by intramural hemorrhage creating a false lumen, with or without an intimal tear. SCAD nearly always presents as an acute myocardial infarction. The prevalence of SCAD varies depending on the population studied. A goal of iSCAD Registry is to expand diversity of race, ethnicity, and sex of study participants. The mean age of SCAD presentation is 45-53 years of age, and appears to primarily affect women.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Participants with a new diagnosis of SCAD or a history of confirmed or suspected SCAD will be prospectively recruited from either:
Participants must be:
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Descriptive Data
Participant demographic, historical, clinical characteristics, and treatment data
Time frame: Continuous time frame following index event for an average of 3 years from study contact date
Clinical Outcomes
Prospectively collected long-term outcomes including recurrent myocardial infarction, hospitalization, heart failure, stroke or transient ischemic attack, arrhythmia, and all cause mortality
Time frame: Continuous time frame following index event for an average of 3 years from study contact date
Psychosocial Outcomes
Prospectively collected data on participant's mental health using validated questionnaires
Time frame: Continuous time frame following index event for an average of 3 years from study contact date
Started Mar 2019 (actual). Primary completion is estimated for Dec 2026, 93 months after the start.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Coronary Artery Dissection, Spontaneous →